期刊文献+

肾癌分子靶向治疗新进展 被引量:2

原文传递
导出
摘要 用于肾癌分子靶向治疗研究常用的靶点包括具有靶向性的表皮生长因子受体(EGFR)阻断剂、抗肿瘤血管生成的药物、针对某些特定细胞标志物的单克隆抗体、针对某些癌基因和癌细胞遗传学标志的药物以及基因治疗等。
出处 《国际泌尿系统杂志》 2006年第3期306-309,共4页 International Journal of Urology and Nephrology
关键词 肾肿瘤
  • 相关文献

参考文献18

  • 1Baselga J,Arteaga CL.Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.J Clin Oncol,2005,23:2445-59.
  • 2Bukowske RM.Epidermal growth factor receptor expression in renal cell carcinoma:rationale for therapy with sidling blockade.Curr Oncol Rep.2005,7:87-89.
  • 3Sumitomo M,Asano T,Asakuma J,et al.ZD1839 modulates paclitaxel response in renal cancer by blocking paclitaxel-induced activation of the epidermal growth factor recptor-extracellular signal-regulated kinase pathway.Clin Cancer Res.2004,10:794-801.
  • 4Sato K,Kakinum H.Quantitiative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.Tohoku J Exp Med,2001,195:101-113.
  • 5Yang JC,Haworth L,Sherry RM,et al.A randomized trial of vacizumab,an anti-vascular endothelial growth factor antibody for metastatic renal cancer.N Engl J Med,2003,349:427-434.
  • 6Potter CP,Harris AL.Diagnostic,prognostic and therapeutic implications of carbonic anhydrases in cancer.Br J Cancer,2003,89:2-7.
  • 7Stadick H,Stockmeyer B,Kuhn R,et al.Epidermal growth factor receptor and g250:useful target antigens for antibody mediated cellular cytotoxicity against renal cell carcinoma? J Urol.2002,167:707-712.
  • 8Bleumer I,Knuth A,Oosterwijk E,et al.A phase 2 trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma paients.Br J Cancer,2004,90:985-990.
  • 9Kassis AI,Adelstein S J,Mariani G.Radiolabeled nucleoside analogs in cancer diagnosis and therapy.J Nucl Med,1996,40:301-319.
  • 10郑骏年,孙晓青,陈家存,温儒民,李望,刘俊杰.^(125)I偶联Ki-67反义核酸对人肾癌细胞生长及凋亡的调控作用[J].中华实验外科杂志,2004,21(3):290-291. 被引量:7

共引文献6

同被引文献15

  • 1郭三维,董柏君,黄翼然.肾癌预后分析的研究进展[J].国际泌尿系统杂志,2006,26(3):309-315. 被引量:12
  • 2张秉鸿,王晓雄.肿瘤内淋巴管形成与肿瘤转移研究进展[J].国际泌尿系统杂志,2006,26(6):785-789. 被引量:1
  • 3刘利维,韩瑞发,刘春雨.保留肾单位手术和肾癌根治术治疗小肾癌疗效比较的Meta分析[J].中华泌尿外科杂志,2007,28(10):668-370.
  • 4Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015 [ J]. CA Cancer J Clin ,2015,65 ( 1 ) :5 - 29. DOI : 10. 3322/caac. 21254.
  • 5Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009 [ J ]. CA Cancer J Clin,2009,59 (4) : 225 - 249. DOI : 10. 3322/caac. 20006.
  • 6Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J]. CA Cancer J Clin,2012,62 ( 1 ) : 10 - 29. DOI: 10. 3322/caac. 20138.
  • 7Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update [ J ]. Eur Urol, 2015,67 ( 5 ) : 913 -924. DOI:10. 1016/j. eururo. 2015.01. 005.
  • 8Kutikov A, Uzzo RG. The R. E. N. A. L, nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth [ J ]. J Urol, 2009,182 ( 3 ) : 844 - 853. DOI: 10. 1016/j. jure. 2009.05. 035.
  • 9Ficarra V, Novara G, Seeco S, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of re- nal turnouts in patients who are candidates for nephron - sparing surgery[J]. Eur Urol,2009,56(5) :786 -793. DOI:IO. 1016/ j. eurure. 2009.07. 040.
  • 10Zhou L, Guo J, Wang H, et al. The Zhongshan score: a novel and simple anatomic classification system to predict perioperative outcomes of nephron - sparing surgery [ J ]. Medicine ( Balti- more) ,2015,94(5) :e506.10. 1097/MD. 0000000000000506.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部